SCHEMBL30962791

SCHEMBL30962791

N#Cc1ccc(Cl)c(NC(=O)c2cnc(Cl)nc2Cl)c1

nearest known ligand 0.50

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ NFKB1 P19838 4/20 0.50
▸ JUN P05412 2/20 0.50
▸ NFKB2 Q00653 2/20 0.50
▸ RELA Q04206 2/20 0.50
▸ KMT2A Q03164 3/20 0.48
▸ PPARG P37231 6/20 0.47
▸ MEN1 O00255 2/20 0.44
▸ L3MBTL1 Q9Y468 1/20 0.44
▸ SMN1; SMN2 Q16637 3/20 0.43
▸ ALDH1A1 P00352 2/20 0.43
▸ KDM4E B2RXH2 1/20 0.43
▸ HPGD P15428 1/20 0.43
▸ HSD17B10 Q99714 1/20 0.43
▸ TMPRSS4 Q9NRS4 1/20 0.42
▸ PKM P14618 1/20 0.42
▸ ATF1 P18846 2/20 0.41
▸ LMNA P02545 1/20 0.40
▸ F10 P00742 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16088827 0.74 HTT (0.61) KMT2APPARGSMN1; SMN2ALDH1A1HPGD
SCHEMBL16088601 0.73 KMT2A (0.51) KMT2APPARGMEN1SMN1; SMN2ALDH1A1
SCHEMBL30962629 0.73 NFKB1 (0.44) NFKB1JUNNFKB2RELAATF1
SCHEMBL30962852 0.73 NFKB1 (0.47) NFKB1JUNNFKB2RELAKMT2A
SCHEMBL19347293 0.73 EGLN1 (0.69) KMT2AMEN1ALDH1A1PKM
SCHEMBL23864300 0.72 KMT2A (0.47) KMT2APPARGMEN1SMN1; SMN2HPGD
SCHEMBL13170059 0.71 ALDH1A1 (0.54) KMT2AMEN1L3MBTL1SMN1; SMN2ALDH1A1
SCHEMBL22145717 0.71 MAPT (0.54) NFKB1JUNNFKB2RELAKMT2A
SCHEMBL24951632 0.71 RAB9A (0.52) NFKB1JUNNFKB2RELAKMT2A
SCHEMBL2946609 0.71 NFKB1 (0.52) NFKB1JUNNFKB2RELAKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4642767-A1 PYRIMIDINE CARBOXAMIDE COMPOUNDS Acrivon Therapeutics, Inc. (US) 2025-11-05 — — EP disclosed
WO-2024145505-A1 PYRIMIDINE CARBOXAMIDE COMPOUNDS ACRIVON THERAPEUTICS, INC. (US) 2024-07-04 — — WO disclosed
Send feedback